Fortis Launches Fortis Institute of Genomic Medicine
Gurugram: Fortis Healthcare, backed by its advanced clinical ecosystem and Agilus Diagnostics, has launched the Fortis Institute of Genomic Medicine. This institute aims to integrate genomic science into patient care across medical specialties.
The institute will bring together a multidisciplinary team of medical experts, including Molecular Haematology, Oncology, Neurology, Paediatrics, Pathology, Genomic scientists, bioinformaticians, and AI engineers.
Fortis stated that the application of genomic science will aid in early diagnosis and personalized treatment across fields such as oncology, cardiology, and neurology. In oncology, genomic testing will assist in identifying cancer-linked genetic mutations, allowing clinicians to select targeted therapies. In cardiology, it will support early identification of inherited cardiac conditions, and in neurology, it will assist in diagnosing complex neurological disorders.
The company shared examples of past applications where genomic analysis changed clinical approaches, including treatment redirection for a leukaemia patient, early intervention for individuals at risk of hereditary cancer, and a shift to targeted therapy in a lung cancer case identified through next-generation sequencing.
Anil Vinayak, Group Chief Operating Officer of Fortis Healthcare, said the initiative will help deliver data-based healthcare by incorporating genomic testing into the care pathway.
Dr. Ritu Garg, Chief Innovation and Growth Officer, said the institute aligns with Fortis’ objective to combine clinical services with advanced science to improve treatment outcomes.
Yash Rawat, Facility Director of Fortis Memorial Research Institute (FMRI), Gurugram, said genomic insights can support early detection and personalized care in chronic and non-communicable diseases.
Fortis also plans to introduce a genomics-informed health registry and an AI-powered genomic reporting platform tailored for Indian clinicians. The platform will follow standards set by international organisations such as the American College of Medical Genetics and Genomics (ACMG), the Association for Molecular Pathology (AMP), and the American Society of Clinical Oncology (ASCO).
Medical professionals participating in the launch included Dr. Rahul Bhargava, Dr. Vinayak Agarwal, Dr. Praveen Gupta, Dr. Nitesh Rohatgi, Dr. Ankur Bahl, Dr. Shrinidhi Nathany, Dr. Ritu Garg, and Mr. Yash Rawat.
Published On Apr 19, 2025 at 06:29 AM IST
Reference : https://health.economictimes.indiatimes.com/news/hospitals/fortis-healthcare-launches-genomic-medicine-institute-to-expand-precision-medicine-access/120421188
